Prosight Management’s Aldeyra Therapeutics ALDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-149,511	Closed	-$1.25M	–	43
2023 Q2	$1.25M	Sell	149,511 -233,936	-61%	-$2.3M	0.37%	32
2023 Q1	$3.81M	Sell	383,447 -475,262	-55%	-$3.36M	1.82%	23
2022 Q4	$5.98M	Sell	858,709 -352,091	-29%	-$2.01M	3.34%	11
2022 Q3	$6.47M	Sell	1,210,800 -775,083	-39%	-$4.65M	3.55%	10
2022 Q2	$7.92M	Buy	1,985,883 +585,644	+42%	+$2.01M	6.42%	6
2022 Q1	$6.22M	Buy	1,400,239 +244,939	+21%	+$976K	4.38%	8
2021 Q4	$4.62M	Buy	1,155,300 +420,300	+57%	+$3.21M	3.08%	14
2021 Q3	$6.45M	Buy	735,000 +139,761	+23%	+$1.28M	3.77%	8
2021 Q2	$6.74M	Buy	595,239 +121,793	+26%	+$1.46M	4.27%	7
2021 Q1	$5.63M	Sell	473,446 -435,042	-48%	-$5.01M	4.61%	8
2020 Q4	$6.23M	Sell	908,488 -183,512	-17%	-$1.29M	3.14%	15
2020 Q3	$8.09M	Sell	1,092,000 -528,200	-33%	-$3.41M	3.99%	9
2020 Q2	$6.76M	Sell	1,620,200 -415,140	-20%	-$1.52M	3.35%	13
2020 Q1	$5.03M	Buy	2,035,340 +607,063	+43%	+$2.73M	2.36%	17
2019 Q4	$8.3M	Buy	1,428,277 +638,049	+81%	+$3.69M	3.79%	12
2019 Q3	$4.17M	Buy	790,228 +92,307	+13%	+$497K	2.32%	17
2019 Q2	$4.19M	Buy	697,921 +114,621	+20%	+$863K	2.13%	17
2019 Q1	$5.27M	Buy	583,300 +178,837	+44%	+$1.52M	2.42%	15
2018 Q4	$3.36M	Buy	+404,463	New	+$4.14M	1.73%	23